Close
Patheon

News Releases

  • 17 Feb 2016

    Patheon Introduces Xcelodose® Automated Encapsulator Technology at Milton Park, U.K. Facility

    Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, has added a new filling technology that significantly reduces the time needed for formulation development and stability testing at its Milton Park, U.K., facility. The Xcelodose ® 600 S Automated Encapsulator, supports early phase development for oral dose products.This technology adds to the site’s breadth of services, from early development to life cyclemore...
  • 08 Feb 2016
    DURHAM, N.C.--(BUSINESS WIRE)--Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma industries, has hired Andrew G. Long as senior vice president and global business controller. Long will report to Stuart Grant, chief financial officer for Patheon, and will be based at the company’s headquarters in Durham, N.C. Long will focus on Patheon’s financial planning and performance management toolsmore...
  • 02 Feb 2016

    Industry Veteran, Steve Lam, to Direct Rapidly Expanding Business

    DURHAM, N.C.--(BUSINESS WIRE)--Patheon today announced the appointment of Steve Lam as senior vice president of the company’s biologics business. Lam will report to Lukas Utiger, president of the company’s Drug Substance Services (DSS) segment, effective immediately. Biologics is a fast-growing area of the industry, which requires experience and expertise because of their complexity. For the past 18 years, Lam has served as vice president of operations for Amgen, onemore...

Media Contact

Mari Mansfield
4815 Emperor Blvd.,
Durham, NC 27703
(919) 226-3137
mari.mansfield@patheon.com

 
 

Media Contact

Mari Mansfield
4815 Emperor Blvd.,
Durham, NC 27703
(919) 226-3137
mari.mansfield@patheon.com